Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia.

Hematology/oncology clinics of North America - 1 Aug 2023

Moreno David F, Fernández de Larrea Carlos

Abstract excerpt

With the increasing availability of sequencing techniques and new polymerase chain reaction-based methods, data regarding the genomic profile of Waldenström macroglobulinemia (WM) are being continuously analyzed and reproduced. MYD88 and CXCR4 mutations are highly prevalent in all the stages of WM, including the early IgM monoclonal gammopathy of undetermined significance or a more advanced stage, such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics
Share to Lymphoma, B-Cell
Share to Monoclonal Gammopathy of Undetermined Significance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myeloid Differentiation Factor 88

Share to Waldenstrom Macroglobulinemia

Source

Identifiers

PMID: 37211494
DOI: 10.1016/j.hoc.2023.04.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia.PMID 37211494Read ↗

Genomic Landscape of Waldenström Macroglobulinemia.Semantic proximity Read ↗

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.Semantic proximity Read ↗

Clinical application of genomics in Waldenström macroglobulinemia.Semantic proximity Read ↗

Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.Semantic proximity Read ↗

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.Semantic proximity Read ↗

New treatment strategies for Waldenström macroglobulinemia.Semantic proximity Read ↗

New developments in the diagnosis and characterization of Waldenström's macroglobulinemia.Semantic proximity Read ↗

Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.Semantic proximity Read ↗

The Evolution and Subtypes of Waldenstrom Macroglobulinemia: Findings from a Multi-omic Analysis of 249 Treatment Naive MYD88L265P Mutated Patients.Semantic proximity Read ↗

Waldenstrom macroglobulinemia: genetics dictates clinical course.Semantic proximity Read ↗

Toward personalized treatment in Waldenström macroglobulinemia.Semantic proximity Read ↗

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.